Work

Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density

Year: 2009

Type: article

Source: Bone

DOI: 10.1016/j.bone.2009.01.227

Authors: J.A. Eisman, R.R. Recker, M. McClung, H. Bone, C. Roux, N. Verbruggen, C.M. Hustad, C. DaSilva, A. Santora, A. Ince

Institutions: Garvan Institute of Medical Research, UNSW Sydney, St Vincent's Hospital Sydney, Creighton University, Université Paris Cité, Hôpital Cochin, MSD (Belgium), Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Bone health and osteoporosis research

Subfield: Orthopedics and Sports Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1988828017

FWCI: 0.349

Cites:

Cited by: 1

Related to: 10